Treatment options for patients with triple-negative breast cancer

por Santana-Davila, Rafael, Perez, Edith A
Publicado 2010

Immunotherapy for Head and Neck Cancer in the Era of Exponentially Increasing Health Care Expenditure

por Santana‐Davila, Rafael, Rodriguez, Cristina P.
Publicado 2017

A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache

por Jackson, Jeffrey L., Cogbill, Elizabeth, Santana-Davila, Rafael, Eldredge, Christina, Collier, William, Gradall, Andrew, Sehgal, Neha, Kuester, Jessica
Publicado 2015

A phase I study of pazopanib in combination with escalating doses of (131)I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine

por Chow, Laura Q., Santana-Davila, Rafael, Pantel, Austin, Roth, Mara, Anderson, Leslie N., Failor, Alan, Doot, Robert, Mankoff, David
Publicado 2017

Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial

por Chau, Ian, Penel, Nicolas, Soriano, Andres O., Arkenau, Hendrik-Tobias, Cultrera, Jennifer, Santana-Davila, Rafael, Calvo, Emiliano, Le Tourneau, Christophe, Zender, Lars, Bendell, Johanna C., Mi, Gu, Gao, Ling, McNeely, Samuel Clark, Oliveira, Joana M., Ferry, David, Herbst, Roy S., Fuchs, Charles S.
Publicado 2020

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

por Chalker, Cameron, Voutsinas, Jenna M., Wu, Qian Vicky, Santana‐Davila, Rafael, Hwang, Victoria, Baik, Christina S., Lee, Sylvia, Barber, Brittany, Futran, Neal D., Houlton, Jeffrey J., Laramore, George E., Liao, Jay Justin, Parvathaneni, Upendra, Martins, Renato G., Eaton, Keith D., Rodriguez, Cristina P.
Publicado 2022

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chem...

por Bowen, Stephen R., Hippe, Daniel S., Thomas, Hannah M., Sasidharan, Balukrishna, Lampe, Paul D., Baik, Christina S., Eaton, Keith D., Lee, Sylvia, Martins, Renato G., Santana-Davila, Rafael, Chen, Delphine L., Kinahan, Paul E., Miyaoka, Robert S., Vesselle, Hubert J., Houghton, A. McGarry, Rengan, Ramesh, Zeng, Jing
Publicado 2021

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

por Forde, Patrick M., Anagnostou, Valsamo, Sun, Zhuoxin, Dahlberg, Suzanne E., Kindler, Hedy L., Niknafs, Noushin, Purcell, Thomas, Santana-Davila, Rafael, Dudek, Arkadiusz Z., Borghaei, Hossein, Lanis, Mara, Belcaid, Zineb, Smith, Kellie N., Balan, Archana, White, James R., Cherry, Christopher, Ashok Sivakumar, I. K., Shao, Xiaoshan M., Chan, Hok Yee, Singh, Dipika, Thapa, Sampriti, Illei, Peter B., Pardoll, Drew M., Karchin, Rachel, Velculescu, Victor E., Brahmer, Julie R., Ramalingam, Suresh S.
Publicado 2021